Choosing the Right Multiple Sclerosis Treatment for Your Lifestyle

Multiple sclerosis (MS) can be managed with disease-modifying therapies (DMTs) that slow progression, reduce relapses, and improve quality of life. DMTs come in three main forms—self‑injectable, infusion, and oral—each with distinct administration requirements, efficacy, and side‑effect profiles. Understanding these differences helps you and your healthcare team choose the option that fits your daily routine and health goals.

Self‑Injectable DMTs

These medications are administered at home using a syringe, pen, or auto‑injector. After proper training from a clinician, you can inject subcutaneously (under the skin) or intramuscularly.

FDA‑approved self‑injectables

• Glatiramer acetate (Copaxone, Glatopa) – 20 mg or 40 mg
• Interferon beta‑1a (Avonex, Rebif)
• Interferon beta‑1b (Betaseron, Extavia)
• Ofatumumab (Kesimpta)
• Peginterferon beta‑1a (Plegridy)

Injection frequency ranges from daily (Copaxone, Glatopa) to monthly (Kesimpta after the initial 3‑week loading phase).

Who might prefer self‑injectables?

If you are comfortable with self‑administration and want to avoid daily pills, injectable DMTs can be a convenient choice.

Common side effects & management

• Injection‑site pain, redness, or swelling
• Flu‑like symptoms (fever, aches)
• Liver‑function test abnormalities

Strategies to reduce discomfort include rotating injection sites, using a smaller needle or auto‑injector, applying ice before injection, and taking an OTC pain reliever such as acetaminophen.

Infusion DMTs

Infusion therapies are given intravenously in a clinic or infusion center under professional supervision. You must be able to attend regular appointments.

FDA‑approved infusion options

• Alemtuzumab (Lemtrada)
• Mitoxantrone (Novantrone)
• Natalizumab (Tysabri)
• Ocrelizumab (Ocrevus)
• Ublituximab (Briumvi)

Typical infusion schedules:

• Lemtrada – two courses: 5 daily infusions, then 1 year later 3 daily infusions
• Novantrone – every 3 months
• Tysabri – every 4 weeks
• Ocrevus & Briumvi – first two doses 2 weeks apart, then every 6 months

Who might choose infusions?

If you prefer a healthcare professional to handle administration or want to avoid frequent injections or pills, infusions may suit you.

Side effects & safety measures

• Nausea, headache, abdominal discomfort, fever, flushing, rash at the site
• Rare but serious risks: infections, cardiac toxicity

Premedication with antihistamines, antipyretics, or anti‑nausea drugs can lessen acute reactions. Patients with asthma should bring a rescue inhaler, and women of child‑bearing potential may need birth‑control counseling.

Oral DMTs

Oral medications are taken at home and are popular for their convenience. A 2015 study showed a strong patient preference for daily pills.

FDA‑approved oral agents

• Cladribine (Mavenclad) – short‑course, 16–20 treatment days over 2 years
• Dimethyl fumarate (Tecfidera) – twice daily
• Dimethyl fumarate (generic) – twice daily
• Diroximel fumarate (Vumerity) – twice daily (initial week 1 pill × 2, then 2 pills × 2)
• Fingolimod (Gilenya, Tascenso ODT) – once daily
• Monomethyl fumarate (Bafiertam) – twice daily
• Ozanimod (Zeposia) – once daily
• Ponesimod (Ponvory) – once daily
• Siponimod (Mayzent) – once daily
• Teriflunomide (Aubagio) – once daily

Who might prefer oral therapy?

If you dislike needles and can maintain a regular dosing schedule, oral DMTs are often the easiest option. Setting reminders can help you stay consistent.

Side effects & dose titration

• Headache, gastrointestinal upset, liver‑test abnormalities

Physicians often start with a low dose and gradually increase it to improve tolerability. Taking the medication with food and using OTC remedies such as Pepto‑Bismol for stomach upset can be helpful.

Additional Considerations

Vaccinations

Before starting or continuing DMTs, discuss vaccination timing with your clinician. Live vaccines are generally avoided while on immunomodulatory therapy. Recommended vaccines include COVID‑19, influenza, hepatitis B, shingles, pneumococcal, HPV, and varicella, among others. A waiting period may be needed between vaccination and DMT initiation for optimal effectiveness.

JC Virus Testing

For therapies like natalizumab, testing for John Cunningham (JC) virus reactivation is required because reactivation can lead to progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection. A positive test does not guarantee PML but influences treatment decisions.

Making the Right Choice

Choosing a DMT involves balancing efficacy, side‑effect profile, administration method, and how the regimen fits into your daily life. Work closely with a neurologist or MS specialist who can:

• Evaluate disease activity and personal health factors
• Discuss the pros and cons of each route
• Provide training for self‑injection or set up infusion appointments
• Monitor labs and adjust dosing as needed

Most DMTs take 6–12 months to show their full benefit, so patience and regular follow‑up are essential. Contact your healthcare team promptly if you notice new or worsening symptoms.